VCM
ELVN icon

Versant Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Versant Capital Management’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$5.6K Buy
279
+212
+316% +$4.25K ﹤0.01% 2113
2025
Q1 		$1.32K Hold
67
– – ﹤0.01% 2321
2024
Q4 		$1.51K Hold
67
– – ﹤0.01% 2113
2024
Q3 		$1.71K Buy
+67
New +$1.71K ﹤0.01% 1610